Stroma: the forgotten cells of innate immune memory

Clinical and Experimental Immunology

Volumn 193, Issue 1, 2018, Pages 24-36

  Crowley, T ^a   Buckley, C D ^a,b   Clark, A R ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

endothelial cell; fibroblast; inflammation; innate immune memory; stromal memory

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON;

BONE MARROW CELL; CHROMATIN; ENDOTHELIUM CELL; EPIGENETICS; EVIDENCE BASED PRACTICE; FIBROBLAST; HUMAN; IMMUNOLOGICAL MEMORY; INFLAMMATION; INFLAMMATORY DISEASE; INNATE IMMUNITY; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STROMA CELL; IMMUNOLOGY; PATHOLOGY;

ENDOTHELIAL CELLS; FIBROBLASTS; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC MEMORY; INFLAMMATION; STROMAL CELLS;

EID: 85049782693     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.13149     Document Type: Review

References (91)

1. Netea MG, Quintin J, van der Meer JW. Trained immunity: a memory for innate host defense. Cell Host Microbe 2011; 9:355–61.
2. Naeslund C. Experience of vaccination with BCG in the province of Norrbotten (Sweden). Tuberculosis Review 1931; 12:617–36.
3. Kleinnijenhuis J, Quintin J, Preijers F et al. Bacille Calmette–Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci USA 2012; 109:17537–42.
4. Quintin J, Saeed S, Martens JH et al. Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host Microbe 2012; 12:223–32.
5. Netea MG, van der Meer JW. Trained immunity: an ancient way of remembering. Cell Host Microbe 2017; 21:297–300.
6. Gardiner CM, Mills KH. The cells that mediate innate immune memory and their functional significance in inflammatory and infectious diseases. Semin Immunol 2016; 28:343–50.
7. Naik S, Larsen SB, Gomez NC et al. Inflammatory memory sensitizes skin epithelial stem cells to tissue damage. Nature 2017; 550:475–80.
8. Dai X, Medzhitov R. Inflammation: memory beyond immunity. Nature 2017; 550:460–1.
9. Pate M, Damarla V, Chi DS, Negi S, Krishnaswamy G. Endothelial cell biology: role in the inflammatory response. Adv Clin Chem 2010; 52:109–30.
10. Hall SE, Savill JS, Henson PM, Haslett C. Apoptotic neutrophils are phagocytosed by fibroblasts with participation of the fibroblast vitronectin receptor and involvement of a mannose/fucose-specific lectin. J Immunol 1994; 153:3218–27.
11. Boots AM, Wimmers-Bertens AJ, Rijnders AW. Antigen-presenting capacity of rheumatoid synovial fibroblasts. Immunology 1994; 82:268–74.
12. McGettrick HM, Butler LM, Buckley CD, Rainger GE, Nash GB. Tissue stroma as a regulator of leukocyte recruitment in inflammation. J Leukoc Biol 2012; 91:385–400.
13. McGettrick HM, Smith E, Filer A et al. Fibroblasts from different sites may promote or inhibit recruitment of flowing lymphocytes by endothelial cells. Eur J Immunol 2009; 39:113–25.
14. Filer A, Ward LSC, Kemble S et al. Identification of a transitional fibroblast function in very early rheumatoid arthritis. Ann Rheum Dis 2017; 76:2105–12.
15. Van Linthout S, Miteva K, Tschöpe C. Crosstalk between fibroblasts and inflammatory cells. Cardiovasc Res 2014; 102:258–69.
16. Mor A, Abramson SB, Pillinger MH. The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction. Clin Immunol 2005; 115:118–28.
17. Kaplanski G, Marin V, Montero-Julian F, Mantovani A, Farnarier C. IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation. Trends Immunol 2003; 24:25–9.
18. Navarro-Xavier RA, Newson J, Silveira VL, Farrow SN, Gilroy DW, Bystrom J. A new strategy for the identification of novel molecules with targeted proresolution of inflammation properties. J Immunol 2010; 184:1516–25.
19. Greenlee-Wacker MC. Clearance of apoptotic neutrophils and resolution of inflammation. Immunol Rev 2016; 273:357–70.
20. Beeson PB, Roberts TAoE. Tolerance to bacterial pyrogens: II. Role of the reticulo-endothelial system. J Exp Med 1947; 86:39–44.
21. Hollingsworth JW, Atkins E. Synovial inflammatory response to bacterial endotoxin. Yale J Biol Med 1965; 38:241–56.
22. Foster SL, Hargreaves DC, Medzhitov R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 2007; 447:972–8.
23. Hamers L, Kox M, Pickkers P. Sepsis-induced immunoparalysis: mechanisms, markers, and treatment options. Minerva Anestesiol 2015; 81:426–39.
24. Tamura M, Tokuda M, Nagaoka S, Takada H. Lipopolysaccharides of Bacteroides intermedius (Prevotella intermedia) and Bacteroides (Porphyromonas) gingivalis induce interleukin-8 gene expression in human gingival fibroblast cultures. Infect Immun 1992; 60:4932–7.
25. Lee TH, Lee GW, Ziff EB, Vilcek J. Isolation and characterization of eight tumor necrosis factor-induced gene sequences from human fibroblasts. Mol Cell Biol 1990; 10:1982–8.
26. Sakuta T, Tokuda M, Tamura M et al. Dual regulatory effects of interferon-alpha, -beta, and -gamma on interleukin-8 gene expression by human gingival fibroblasts in culture upon stimulation with lipopolysaccharide from Prevotella intermedia, interleukin-1alpha, or tumor necrosis factor-alpha. J Dent Res 1998; 77:1597–605.
27. Wolchok JD, Vilcek J. Induction of HLA class I mRNA by cytokines in human fibroblasts: comparison of TNF, IL-1 and IFN-beta. Cytokine 1992; 4:520–7.
28. Oliveira IC, Sciavolino PJ, Lee TH, Vilcek J. Downregulation of interleukin 8 gene expression in human fibroblasts: unique mechanism of transcriptional inhibition by interferon. Proc Natl Acad Sci USA 1992; 89:9049–53.
29. Ospelt C, Reedquist KA, Gay S, Tak PP. Inflammatory memories: is epigenetics the missing link to persistent stromal cell activation in rheumatoid arthritis? Autoimmun Rev 2011; 10:519–24.
30. Owens BM. Inflammation, innate immunity, and the intestinal stromal cell niche: opportunities and challenges. Front Immunol 2015; 6:319.
31. Dakin SG, Martinez FO, Yapp C et al. Inflammation activation and resolution in human tendon disease. Sci Transl Med 2015; 7:311ra173.
32. Ara T, Kurata K, Hirai K et al. Human gingival fibroblasts are critical in sustaining inflammation in periodontal disease. J Periodontal Res 2009; 44:21–7.
33. Zaric SS, Coulter WA, Shelburne CE et al. Altered Toll-like receptor 2-mediated endotoxin tolerance is related to diminished interferon beta production. J Biol Chem 2011; 286:29492–500.
34. Sohn C, Lee A, Qiao Y, Loupasakis K, Ivashkiv LB, Kalliolias GD. Prolonged tumor necrosis factor α primes fibroblast-like synoviocytes in a gene-specific manner by altering chromatin. Arthritis Rheumatol 2015; 67:86–95.
35. Dakin SG, Newton J, Martinez FO et al. Chronic inflammation is a feature of Achilles tendinopathy and rupture. Br J Sports Med 2017; 52: 359–367.
36. Dakin SG, Buckley CD, Al-Mossawi MH et al. Persistent stromal fibroblast activation is present in chronic tendinopathy. Arthritis Res Ther 2017; 19:16.
37. Crowley T, O'Neil JD, Adams H et al. Priming in response to pro-inflammatory cytokines is a feature of adult synovial but not dermal fibroblasts. Arthritis Res Ther 2017; 19:35.
38. Klein K, Frank-Bertoncelj M, Karouzakis E et al. The epigenetic architecture at gene promoters determines cell type-specific LPS tolerance. J Autoimmun 2017; 83:122–33.
39. Sohn C, Lee A, Qiao Y, Loupasakis K, Ivashkiv LB, Kalliolias GD. Prolonged TNFα primes fibroblast-like synoviocytes in a gene-specific manner by altering chromatin. Arthritis Rheumatol 2014; 67:86–95.
40. Silverman MD, Tumuluri RJ, Davis M, Lopez G, Rosenbaum JT, Lelkes PI. Homocysteine upregulates vascular cell adhesion molecule-1 expression in cultured human aortic endothelial cells and enhances monocyte adhesion. Arterioscler Thromb Vasc Biol 2002; 22:587–92.
41. Wang W, Deng M, Liu X, Ai W, Tang Q, Hu J. TLR4 activation induces nontolerant inflammatory response in endothelial cells. Inflammation 2011; 34:509–18.
42. Koch SR, Lamb FS, Hellman J, Sherwood ER, Stark RJ. Potentiation and tolerance of toll-like receptor priming in human endothelial cells. Transl Res 2017; 180:53–67.e4.
43. Chaudhury H, Zakkar M, Boyle J et al. c-Jun N-terminal kinase primes endothelial cells at atheroprone sites for apoptosis. Arterioscler Thromb Vasc Biol 2010; 30:546–53.
44. Zakkar M, Chaudhury H, Sandvik G et al. Increased endothelial mitogen-activated protein kinase phosphatase-1 expression suppresses proinflammatory activation at sites that are resistant to atherosclerosis. Circ Res 2008; 103:726–32.
45. Oliveira SD, Quintas LE, Amaral LS, Noël F, Farsky SH, Silva CL. Increased endothelial cell-leukocyte interaction in murine schistosomiasis: possible priming of endothelial cells by the disease. PLOS ONE 2011; 6:e23547.
46. Séguin C, Abid MR, Spokes KC et al. Priming effect of homocysteine on inducible vascular cell adhesion molecule-1 expression in endothelial cells. Biomed Pharmacother 2008; 62:395–400.
47. Zemani F, Silvestre JS, Fauvel-Lafeve F et al. Ex vivo priming of endothelial progenitor cells with SDF-1 before transplantation could increase their proangiogenic potential. Arterioscler Thromb Vasc Biol 2008; 28:644–50.
48. Stark RJ, Choi H, Koch SR, Fensterheim BA, Lamb FS, Sherwood ER. Endothelial cell tolerance to lipopolysaccharide challenge is induced by monophosphoryl lipid A. Clin Sci (Lond) 2016; 130:451–61.
49. Seeley JJ, Ghosh S. Molecular mechanisms of innate memory and tolerance to LPS. J Leukoc Biol 2017; 101:107–19.
50. Kawasaki T, Kawai T. Toll-like receptor signaling pathways. Front Immunol 2014; 5:461.
51. Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol 2005; 6:1191–7.
52. Murray PJ, Smale ST. Restraint of inflammatory signaling by interdependent strata of negative regulatory pathways. Nat Immunol 2012; 13:916–24.
53. Kobayashi K, Hernandez LD, Galán JE, Janeway CA, Medzhitov R, Flavell RA. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 2002; 110:191–202.
54. Zou XL, Pei DA, Yan JZ, Xu G, Wu P. A20 overexpression inhibits lipopolysaccharide-induced NF-κB activation, TRAF6 and CD40 expression in rat peritoneal mesothelial cells. Int J Mol Sci 2014; 15:6592–608.
55. Cekic C, Casella CR, Sag D et al. MyD88-dependent SHIP1 regulates proinflammatory signaling pathways in dendritic cells after monophosphoryl lipid A stimulation of TLR4. J Immunol 2011; 186:3858–65.
56. Porta C, Rimoldi M, Raes G et al. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. Proc Natl Acad Sci USA 2009; 106:14978–83.
57. Lee A, Qiao Y, Grigoriev G et al. Tumor necrosis factor α induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 2013; 65:928–38.
58. Xiong Y, Medvedev AE. Induction of endotoxin tolerance in vivo inhibits activation of IRAK4 and increases negative regulators IRAK-M, SHIP-1, and A20. J Leukoc Biol 2011; 90:1141–8.
59. Chen J, Ivashkiv LB. IFN-γ abrogates endotoxin tolerance by facilitating Toll-like receptor-induced chromatin remodeling. Proc Natl Acad Sci USA 2010; 107:19438–43.
60. Rosengren S, Corr M, Firestein GS, Boyle DL. The JAK inhibitor CP-690,550 (tofacitinib) inhibits TNF-induced chemokine expression in fibroblast-like synoviocytes: autocrine role of type I interferon. Ann Rheum Dis 2012; 71:440–7.
61. Chen X, Yoza BK, El Gazzar M, Hu JY, Cousart SL, McCall CE. RelB sustains IkappaBalpha expression during endotoxin tolerance. Clin Vaccine Immunol 2009; 16:104–10.
62. Arts RJ, Carvalho A, La Rocca C et al. Immunometabolic pathways in BCG-induced trained immunity. Cell Rep 2016; 17:2562–71.
63. del Fresno C, García-Rio F, Gómez-Piña V et al. Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide-tolerant human monocytes: demonstration in isolated monocytes from cystic fibrosis patients. J Immunol 2009; 182:6494–507.
64. El Gazzar M. HMGB1 modulates inflammatory responses in LPS-activated macrophages. Inflamm Res 2007; 56:162–7.
65. Ostuni R, Piccolo V, Barozzi I et al. Latent enhancers activated by stimulation in differentiated cells. Cell 2013; 152:157–71.
66. Baker B, Maitra U, Geng S, Li L. Molecular and cellular mechanisms responsible for cellular stress and low-grade inflammation induced by a super-low dose of endotoxin. J Biol Chem 2014; 289:16262–9.
67. Loppnow H, Werdan K, Buerke M. Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms. Innate Immun 2008; 14:63–87.
68. Bekkering S, Joosten LA, van der Meer JW, Netea MG, Riksen NP. Trained innate immunity and atherosclerosis. Curr Opin Lipidol 2013; 24:487–92.
69. Bekkering S, Joosten LA, van der Meer JW, Netea MG, Riksen NP. The epigenetic memory of monocytes and macrophages as a novel drug target in atherosclerosis. Clin Ther 2015; 37:914–23.
70. Sitia S, Tomasoni L, Atzeni F et al. From endothelial dysfunction to atherosclerosis. Autoimmun Rev 2010; 9:830–4.
71. Bottini N, Firestein GS. Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat Rev Rheumatol 2013; 9:24–33.
72. Patel R, Filer A, Barone F, Buckley CD. Stroma: fertile soil for inflammation. Best Pract Res Clin Rheumatol 2014; 28:565–76.
73. Parsonage G, Filer AD, Haworth O et al. A stromal address code defined by fibroblasts. Trends Immunol 2005; 26:150–6.
74. Didierlaurent A, Goulding J, Hussell T. The impact of successive infections on the lung microenvironment. Immunology 2007; 122:457–65.
75. Goulding J, Snelgrove R, Saldana J et al. Respiratory infections: do we ever recover? Proc Am Thorac Soc 2007; 4:618–25.
76. Kaynar AM, Yende S, Zhu L et al. Effects of intra-abdominal sepsis on atherosclerosis in mice. Crit Care 2014; 18:469.
77. Yende S, D'Angelo G, Mayr F et al. Elevated hemostasis markers after pneumonia increases one-year risk of all-cause and cardiovascular deaths. PLOS ONE 2011; 6:e22847.
78. Thøstesen LM, Nissen TN, Kjærgaard J et al. Bacillus Calmette–Guérin immunisation at birth and morbidity among Danish children: a prospective, randomised, clinical trial. Contemp Clin Trials 2015; 42:213–8.
79. Karumuthil-Melethil S, Gudi R, Johnson BM, Perez N, Vasu C. Fungal β-glucan, a Dectin-1 ligand, promotes protection from type 1 diabetes by inducing regulatory innate immune response. J Immunol 2014; 193:3308–21.
80. Arens C, Bajwa SA, Koch C et al. Sepsis-induced long-term immune paralysis–results of a descriptive, explorative study. Crit Care 2016; 20:93.
81. Demmer RT, Papapanou PN. Epidemiologic patterns of chronic and aggressive periodontitis. Periodontol 2000 2010; 53:28–44.
82. Vanniasinghe AS, Manolios N, Schibeci S et al. Targeting fibroblast-like synovial cells at sites of inflammation with peptide targeted liposomes results in inhibition of experimental arthritis. Clin Immunol 2014; 151:43–54.
83. Müller-Ladner U, Kriegsmann J, Franklin BN et al. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 1996; 149:1607–15.
84. Ghesquière B, Wong BW, Kuchnio A, Carmeliet P. Metabolism of stromal and immune cells in health and disease. Nature 2014; 511:167–76.
85. Naughton DP, Haywood R, Blake DR, Edmonds S, Hawkes GE, Grootveld M. A comparative evaluation of the metabolic profiles of normal and inflammatory knee-joint synovial fluids by high resolution proton NMR spectroscopy. FEBS Lett 1993; 332:221–5.
86. Chimenti MS, Triggianese P, Conigliaro P, Candi E, Melino G, Perricone R. The interplay between inflammation and metabolism in rheumatoid arthritis. Cell Death Dis 2015; 6:e1887.
87. Cheng SC, Quintin J, Cramer RA et al. mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. Science 2014; 345:1250684.
88. Rinn JL, Bondre C, Gladstone HB, Brown PO, Chang HY. Anatomic demarcation by positional variation in fibroblast gene expression programs. PLOS Genet 2006; 2:e119.
89. Filer A, Antczak P, Parsonage GN et al. Stromal transcriptional profiles reveal hierarchies of anatomical site, serum response and disease and identify disease specific pathways. PLOS ONE 2015; 10:e0120917.
90. Parsonage G, Filer A, Bik M et al. Prolonged, granulocyte-macrophage colony-stimulating factor-dependent, neutrophil survival following rheumatoid synovial fibroblast activation by IL-17 and TNFalpha. Arthritis Res Ther 2008; 10:R47.
91. Filer A, Parsonage G, Smith E et al. Differential survival of leukocyte subsets mediated by synovial, bone marrow, and skin fibroblasts: site-specific versus activation-dependent survival of T cells and neutrophils. Arthritis Rheum 2006; 54:2096–108.